tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB

Seres Therapeutics (MCRB) Technical Analysis

884 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Seres Therapeutics’s (MCRB) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Seres Therapeutics is a Buy.
Seres Therapeutics’s (MCRB) 20-Day exponential moving average is 0.92, while Seres Therapeutics’s (MCRB) share price is $0.92, making it a Sell.
Seres Therapeutics’s (MCRB) 50-Day exponential moving average is 0.90, while Seres Therapeutics’s (MCRB) share price is $0.92, making it a Buy.

Seres Therapeutics (MCRB) Pivot Points

May 18, 2024, 05:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.78
0.83
0.88
0.93
0.97
1.02
1.07
Fibonacci
0.83
0.87
0.89
0.93
0.96
0.99
1.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (MCRB) Moving Averages

May 18, 2024, 05:24 PM
Period
Simple
Exponential
MA5
0.93Sell
0.94Sell
MA10
0.98Sell
0.95Sell
MA20
0.93Sell
0.92Sell
MA50
0.82Buy
0.90Buy
MA100
1.00Sell
1.10Sell
MA200
1.58Sell
1.91Sell
Seres Therapeutics’s (MCRB) 10-Day exponential moving average is 0.95, while Seres Therapeutics’s (MCRB) share price is $0.92, making it a Sell.
Seres Therapeutics’s (MCRB) 100-Day exponential moving average is 1.10, while Seres Therapeutics’s (MCRB) share price is $0.92, making it a Sell.
Seres Therapeutics’s (MCRB) stock price is $0.92 and Seres Therapeutics’s (MCRB) 50-day simple moving average is 0.82, creating a Buy signal.
Seres Therapeutics’s (MCRB) stock price is $0.92 and Seres Therapeutics’s (MCRB) 100-day simple moving average is 1.00, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $0.92 and Seres Therapeutics’s (MCRB) 200-day simple moving average is 1.58, creating a Sell signal.

Seres Therapeutics (MCRB) Technical Indicators

May 18, 2024, 05:24 PM
Name
Value
Implied Action
RSI (14)
50.85
Neutral
STOCH (9,6)
40.61
Neutral
STOCHRSI (14)
39.92
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
32.90
Neutral
Williams %R
-62.39
Buy
CCI (14)
6.46
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
48.48
Neutral
ROC
1.10
Buy
Seres Therapeutics’s (MCRB) Relative Strength Index (RSI) is 50.85, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Trend Strength Indicator (ADX) is 32.90, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Commodity Channel Index (CCI) is 6.46, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Price Rate of Change (ROC) is 1.10, creating a Buy signal.

FAQ

Is MCRB a Buy, Hold, or Sell?
Based on MCRB’s technical indicators, MCRB is a Sell.
    What is MCRB’s RSI (14)?
    MCRB’s RSI (14) is 50.85, which suggests MCRB is a Neutral.
      What is MCRB’s MACD?
      MCRB’s MACD is 0.04, which suggests MCRB is a Buy.
        What is MCRB’s 5-day moving average?
        MCRB’s 5-day moving average is 0.93, which suggests MCRB is a Sell.
          What is MCRB’s 20-day moving average?
          MCRB 20-day moving average is 0.93, which suggests MCRB is a Sell.
            What is MCRB’s 50-day moving average?
            MCRB’s 50-day moving average is 0.82, which suggests MCRB is a Buy.
              What is MCRB’s 200-day moving average?
              MCRB’s 200-day moving average is 1.58, which suggests MCRB is a Sell.
                What is MCRB’s Williams % R (14)?
                MCRB’s Williams % R (14) is -62.39, which suggests MCRB is a Buy.
                  What is MCRB’s CCI (14)?
                  MCRB’s CCI (14) is 6.46, which suggests MCRB is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis